{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "discontinued_date": "07/17/2026",
      "update_type": "New",
      "initial_posting_date": "07/17/2026",
      "package_ndc": "0409-3578-01",
      "generic_name": "Tobramycin Sulfate Injection",
      "contact_info": "844-646-4398",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "ANDA063111"
        ],
        "brand_name": [
          "TOBRAMYCIN"
        ],
        "generic_name": [
          "TOBRAMYCIN"
        ],
        "manufacturer_name": [
          "Hospira, Inc."
        ],
        "product_ndc": [
          "0409-3578"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAMUSCULAR",
          "INTRAVENOUS"
        ],
        "substance_name": [
          "TOBRAMYCIN SULFATE"
        ],
        "rxcui": [
          "597823"
        ],
        "spl_id": [
          "d69232fd-aeae-44b9-9e43-2f2e5bd843be"
        ],
        "spl_set_id": [
          "c5a005b0-7b6f-4e30-df92-9a20b1ca66a1"
        ],
        "package_ndc": [
          "0409-3578-11",
          "0409-3578-01"
        ],
        "unii": [
          "HJT0RXD7JK"
        ]
      },
      "update_date": "07/17/2026",
      "therapeutic_category": [
        "Anti-Infective"
      ],
      "dosage_form": "Injection",
      "presentation": "Tobramycin Sulfate, Injection, 80 mg/2 mL (40 mg/mL); 2 mL Multiple Dose Glass Fliptop Vial (NDC 0409-3578-01)",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "status": "To Be Discontinued"
    }
  ]
}